Macrophages that were genetically modified to express glial-derived neurotrophic factor (GDNF) were found to express modified EVs with GDNF and were shown to slow the progression of PD via a reduction in neuro-inflammation [139]. This evidence concerns the gene GDNF and Parkinson disease.